Compounds > benzocaine

benzocaine and mobiflex

benzocaine has been researched along with mobiflex in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ1
Beaudry, P; Bizat, N; Brandel, JP; Gougerot, A; Haïk, S; Laoues, S; Laplanche, JL; Levavasseur, E; Normant, S; Parrales, V; Privat, N; Ravassard, P; Roussel, J1

Other Studies

2 other study(ies) available for benzocaine and mobiflex

ArticleYear
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
    Toxicological sciences : an official journal of the Society of Toxicology, 2013, Volume: 136, Issue:1

    Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests

2013
An in vivo Caenorhabditis elegans model for therapeutic research in human prion diseases.
    Brain : a journal of neurology, 2021, 10-22, Volume: 144, Issue:9

    Topics: Animals; Animals, Genetically Modified; Benzocaine; Brain; Caenorhabditis elegans; Caenorhabditis elegans Proteins; Disease Models, Animal; Humans; Naloxone; Piroxicam; Prion Diseases; Prion Proteins; Protein Aggregation, Pathological; Tubulin

2021